{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:16Z","timestamp":1792785076691,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIAMS Intramural Research Program","award":["ZIA AR041222"],"award-info":[{"award-number":["ZIA AR041222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer that is responsive to immune checkpoint inhibitors (ICI). On rare occasion, MCC spontaneously regresses. It is speculated that this regression occurs when biopsy-induced antigen shedding precipitates an immune response. Here, we demonstrate the activation of an adaptive immune response in a patient whose tumor underwent spontaneous regression after biopsy. To evaluate the tumor immune microenvironment during regression, we performed quantitative immunohistochemical analysis and T-cell receptor (TCR) sequencing. Relative to baseline, the regressing tumor showed evidence of an activated cytotoxic T-cell response together with increased TCR clonality, greater representation of dominant T-cell clones, and the emergence of novel high-frequency T-cell clones. Similar changes in TCR profiles were observed in an MCC tumor undergoing ICI-induced regression. Taken together, our results provide evidence that the expansion of novel and pre-existing adaptive immune responses drives spontaneous MCC regression.<\/jats:p>","DOI":"10.1038\/s41698-025-00987-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:17:25Z","timestamp":1751357845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Patrick","family":"Hallaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Marte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Gulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Logemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney W.","family":"Hudgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101166","volume":"14","author":"G Radha","year":"2021","unstructured":"Radha, G. & Lopus, M. The spontaneous remission of cancer: current insights and therapeutic significance. Transl. Oncol. 14, 101166 (2021).","journal-title":"Transl. Oncol."},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1684\/ejd.2021.4065","volume":"31","author":"L Ah-Thiane","year":"2021","unstructured":"Ah-Thiane, L., Samimi, M., Kervarrec, T., Khammari, A. & Dr\u00e9no, B. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review. Eur. J. Dermatol. 31, 381\u2013391 (2021).","journal-title":"Eur. J. Dermatol."},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/cup.12812","volume":"43","author":"NM Walsh","year":"2016","unstructured":"Walsh, N. M. Complete spontaneous regression of Merkel cell carcinoma (1986\u20132016): a 30 year perspective. J. Cutan. Pathol. 43, 1150\u20131154 (2016).","journal-title":"J. Cutan. Pathol."},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaad.2021.04.024","volume":"87","author":"VF Garza-Davila","year":"2022","unstructured":"Garza-Davila, V. F., Valdespino-Valdes, J., Barrera, F. J., Ocampo-Candiani, J. & Garza-Rodr\u00edguez, V. Clinical impact of immunotherapy in Merkel cell carcinoma patients: a systematic review and meta-analysis. J. Am. Acad. Dermatol. 87, 121\u2013130 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"987_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker, J. C. et al. Merkel cell carcinoma. Nat. Rev. Dis. Prim. 3, 17077 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1097\/DAD.0000000000000614","volume":"38","author":"P Ahmadi Moghaddam","year":"2016","unstructured":"Ahmadi Moghaddam, P. et al. Complete spontaneous regression of merkel cell carcinoma after biopsy: a case report and review of the literature. Am. J. Dermatopathol. 38, e154\u2013e158 (2016).","journal-title":"Am. J. Dermatopathol."},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","volume":"78","author":"KG Paulson","year":"2018","unstructured":"Paulson, K. G. et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J. Am. Acad. Dermatol. 78, 457\u2013463.e2 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000444317","volume":"8","author":"H Terui","year":"2016","unstructured":"Terui, H., Fujimura, T., Kakizaki, A., Furudate, S. & Aiba, S. Merkel cell carcinoma with spontaneous regression: a case report and immunohistochemical study. Case Rep. Dermatol. 8, 52\u20138 (2016).","journal-title":"Case Rep. Dermatol."},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","volume":"17","author":"HL Kaufman","year":"2016","unstructured":"Kaufman, H. L. et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol. 17, 1374\u20131385 (2016).","journal-title":"Lancet Oncol."},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1158\/1078-0432.CCR-16-0392","volume":"22","author":"L Feldmeyer","year":"2016","unstructured":"Feldmeyer, L. et al. Density, distribution, and composition of immune infiltrates correlate with survival in merkel cell carcinoma. Clin. Cancer Res. 22, 5553\u20135563 (2016).","journal-title":"Clin. Cancer Res."},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","volume":"6","author":"PL Chen","year":"2016","unstructured":"Chen, P. L. et al. Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov. 6, 827\u201337 (2016).","journal-title":"Cancer Discov."},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.jid.2020.02.031","volume":"140","author":"M Farah","year":"2020","unstructured":"Farah, M. et al. T-cell repertoire in combination with T-cell density predicts clinical outcomes in patients with merkel cell carcinoma. J. investig. Dermatol. 140, 2146\u20132156.e4 (2020).","journal-title":"J. investig. Dermatol."},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.trecan.2023.11.007","volume":"10","author":"S Vilbois","year":"2024","unstructured":"Vilbois, S., Xu, Y. & Ho, P. C. Metabolic interplay: tumor macrophages and regulatory T cells. Trends Cancer 10, 242\u2013255 (2024).","journal-title":"Trends Cancer"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/archderm.1991.04510010118015","volume":"127","author":"K Kayashima","year":"1991","unstructured":"Kayashima, K. et al. Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch. Dermatol. 127, 550\u2013553 (1991).","journal-title":"Arch. Dermatol."},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1524-4725.2010.01531.x","volume":"36","author":"C Ciudad","year":"2010","unstructured":"Ciudad, C., Aviles, J. A., Alfageme, F., Lecona, M., Suarez, R. & Lazaro, P. Spontaneous regression in merkel cell carcinoma: report of two cases with a description of dermoscopic features and review of the literature. Dermatol. Surg. 36, 687\u201393 (2010).","journal-title":"Dermatol. Surg."},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0923-1811(00)00103-1","volume":"24","author":"T Inoue","year":"2000","unstructured":"Inoue, T., Yoneda, K., Manabe, M. & Demitsu, T. Spontaneous regression of merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group. J. Dermatol. Sci. 24, 203\u201311 (2000).","journal-title":"J. Dermatol. Sci."},{"key":"987_CR17","first-page":"301","volume":"101","author":"S Branch","year":"2018","unstructured":"Branch, S., Maloney, K. & Purcell, S. M. Spontaneous regression of Merkel cell carcinoma. Cutis 101, 301\u2013305 (2018).","journal-title":"Cutis"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.humpath.2016.02.002","volume":"52","author":"NM Walsh","year":"2016","unstructured":"Walsh, N. M. et al. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma. Hum. Pathol. 52, 190\u20136 (2016).","journal-title":"Hum. Pathol."},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bjps.2006.10.020","volume":"61","author":"MJ Vesely","year":"2008","unstructured":"Vesely, M. J., Murray, D. J., Neligan, P. C., Novak, C. B., Gullane, P. J. & Ghazarian, D. Complete spontaneous regression in Merkel cell carcinoma. J. Plast. Reconstruct. Aesthetic Surg. 61, 165\u201371 (2008).","journal-title":"J. Plast. Reconstruct. Aesthetic Surg."},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1172\/JCI117116","volume":"93","author":"A Mackensen","year":"1994","unstructured":"Mackensen, A. et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Investig. 93, 1397\u2013402 (1994).","journal-title":"J. Clin. Investig."},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<592::AID-IMMU592>3.0.CO;2-2","volume":"29","author":"E Zorn","year":"1999","unstructured":"Zorn, E. & Hercend, T. A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur. J. Immunol. 29, 592\u2013601 (1999).","journal-title":"Eur. J. Immunol."},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"e1652538","DOI":"10.1080\/2162402X.2019.1652538","volume":"8","author":"A Khunger","year":"2019","unstructured":"Khunger, A., Rytlewski, J. A., Fields, P., Yusko, E. C. & Tarhini, A. A. The impact of CTLA-4 blockade and interferon-\u03b1 on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients. Oncoimmunology 8, e1652538 (2019).","journal-title":"Oncoimmunology"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s43018-019-0022-x","volume":"1","author":"S Valpione","year":"2020","unstructured":"Valpione, S. et al. Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy. Nat. Cancer 1, 210\u2013221 (2020).","journal-title":"Nat. Cancer"},{"key":"987_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0450-7","volume":"6","author":"NJ Miller","year":"2018","unstructured":"Miller, N. J. et al. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy. J. Immunother. Cancer 6, 131 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"987_CR25","first-page":"137","volume":"5","author":"NJ Miller","year":"2017","unstructured":"Miller, N. J. et al. Tumor-iInfiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival. Immunol. Res. 5, 137\u2013147 (2017).","journal-title":"Immunol. Res."},{"key":"987_CR26","doi-asserted-by":"publisher","unstructured":"Church, C. et al. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma. J. Immunother. Cancer 10, https:\/\/doi.org\/10.1136\/jitc-2022-005328 (2022).","DOI":"10.1136\/jitc-2022-005328"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:17:26Z","timestamp":1751357846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-00987-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.H., J.W.R., M.B., N.T.H., J.L.M., N.L., C.W.H., A.R., and I.B. declare no conflicts of interest. J.L.G. works for the National Cancer Institute which has a Cooperative Research and Development Agreements (CRADA) with EMD Serono. This CRADA provided resources for the co-development of avelumab in MCC. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or U.S. Government.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors obtained written consent from patients for their photographs and medical information to be published in print and online and with the understanding that this information may be publicly available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"212"}}